Plus Therapeutics to rebrand as Cerenome, trade as CNSY on Aug. 3
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/24/2026
- S&P 500, Nasdaq fall as investors juggle earnings, Mideast risks and tariffs
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil retreats from above $100, still set for weekly rise on Middle East escalation
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- Meta’s new seller app hits eBay where it hurts most
Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding
June 30, 2026 7:30 AM EDTPlus Therapeutics to become Cerenome, to trade under new Nasdaq ticker CNSY on August 3, 2026
Affirms 2026 guidance on key milestones
Reports positive CNSide® commercial progress
HOUSTON, June 30, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (Plus or the Company), a healthcare company focused on central nervous system (CNS) cancers, today provides a comprehensive business update. Notably, the Company announces it is changing its company name from Plus Therapeutics to Cerenome and Nasdaq ticker to CNSY, effective August 3, 2026. Furthermore, the Company affirmed its... More
